These studies reveal that multiple FH-associated GOF mutations in two distinct regions of PCSK9 inhibit LDL binding, and that the Ser-127 residue in PCSK9 plays a critical role. This evidence concerns the gene PCSK9 and familial hyperaldosteronism.